Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of
allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with …

Chronic graft versus host disease (GVHD) remains today one of the most vexing late
complications of allogeneic stem cell transplantation. Occurring a minimum of 100 days …

Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening
complication of allogeneic hematopoietic stem cell transplantation. Increased …

Chronic graft-versus-host disease (CGVHD) is a major cause of morbidity and mortality
following allogeneic bone marrow transplantation (BMT). We studied 159 patients with …

Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that occurs
frequently after allogeneic hematopoietic cell transplantation (HCT). Most cases are …

Chronic graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in long-
term survivors of allogeneic stem cell transplantation. The immunopathogenesis of chronic …

Despite improvements in the practice of allogeneic hematopoietic stem cell transplantation
(HCT) over the last 25 years, chronic graft-versus-host disease (GVHD) remains a …

Chronic graft-versus-host disease (GVHD) has been a difficult problem to address and
clinical research in this area lags behind other innovations in hematopoietic stem cell …

Although transplant practices have changed over the last decades, no information is
available on trends in incidence and outcome of chronic graft-versus-host disease (cGVHD) …

This consensus document is intended to serve 3 functions. First, it standardizes the criteria
for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new …